Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of desloratadine 5 mg tablets (Cadila vs Aerius) in healthy Thai volunteers under fasting conditions
TCTR20200310001Phase 0Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of desloratadine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by Bio-innova. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
desloratadine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on TCTR20200310001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200310001.